Equal Costs for Breast Cancer Diagnostic and Screening Exams
New rules aim to standardize costs and treatment limits for both diagnostic and screening breast cancer examinations. This means insurers cannot impose higher fees or stricter limits on diagnostic tests, which are often needed after an initial screening. As a result, citizens can avoid unexpected, higher costs associated with further diagnosis.
Key points
Health insurers must treat diagnostic breast cancer exams the same as screening exams regarding costs and treatment limits.
Insurers are prohibited from increasing screening exam costs solely to comply with these new requirements.
The law does not mandate replacing screening exams with diagnostic ones, nor does it prevent insurers from requiring prior authorization for tests.
Expired
Citizen Poll